This study is in progress, not accepting new patients
An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia
Summary
- Eligibility
- for people ages 6 years and up (full criteria)
- Location
- at UCLA UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- BioMarin Pharmaceutical
- Links
- NIH Genetics Home Reference related topics: Achondroplasia Description NIH Genetic and Rare Diseases Information Center resources: Achondroplasia
- ID
- NCT03424018
- Phase
- Phase 3 Achondroplasia Research Study
- Study Type
- Interventional
- Participants
- About 119 people participating
- Last Updated